X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5330) 5330
Publication (639) 639
Book Chapter (49) 49
Book Review (47) 47
Conference Proceeding (10) 10
Book / eBook (6) 6
Dissertation (4) 4
Journal / eJournal (2) 2
Magazine Article (2) 2
Data Set (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3580) 3580
index medicus (2635) 2635
invasive aspergillosis (1843) 1843
male (1763) 1763
female (1583) 1583
invasive pulmonary aspergillosis (1545) 1545
infectious diseases (1386) 1386
aspergillosis (1357) 1357
antifungal agents - therapeutic use (1301) 1301
middle aged (1279) 1279
microbiology (1170) 1170
adult (1155) 1155
diagnosis (940) 940
mycoses (856) 856
fungal-infections (841) 841
aged (839) 839
pulmonary aspergillosis (832) 832
mycology (776) 776
animals (731) 731
aspergillus (700) 700
immunology (692) 692
transplantation (688) 688
voriconazole (673) 673
health aspects (626) 626
risk factors (613) 613
infections (606) 606
immunocompromised host (599) 599
invasive fungal-infections (594) 594
amphotericin-b (587) 587
pharmacology & pharmacy (585) 585
aspergillosis - drug therapy (573) 573
antifungal agents (570) 570
epidemiology (565) 565
adolescent (561) 561
hematology (523) 523
retrospective studies (512) 512
aspergillosis - microbiology (486) 486
aspergillosis - diagnosis (474) 474
treatment outcome (471) 471
liposomal amphotericin-b (453) 453
aspergillus fumigatus (452) 452
antifungal agents - administration & dosage (445) 445
mortality (443) 443
child (434) 434
therapy (427) 427
galactomannan (415) 415
infection (413) 413
mice (399) 399
neutropenic patients (395) 395
disease (384) 384
invasive pulmonary aspergillosis - diagnosis (384) 384
care and treatment (383) 383
cancer (381) 381
antifungal agents - pharmacology (380) 380
fungi (380) 380
fungal infections (378) 378
neutropenia (374) 374
risk-factors (374) 374
young adult (372) 372
fumigatus (357) 357
oncology (357) 357
aspergillus - isolation & purification (353) 353
mycoses - drug therapy (351) 351
itraconazole (348) 348
respiratory system (338) 338
research (336) 336
amphotericin b (313) 313
amphotericin b - therapeutic use (313) 313
analysis (306) 306
immunocompromised patients (302) 302
caspofungin (295) 295
prophylaxis (292) 292
sensitivity and specificity (291) 291
invasive pulmonary aspergillosis - drug therapy (289) 289
triazoles - therapeutic use (289) 289
antifungal therapy (282) 282
leukemia (282) 282
medicine & public health (281) 281
stem-cell transplantation (275) 275
veterinary sciences (267) 267
transplant recipients (257) 257
invasive fungal infection (256) 256
management (254) 254
aspergillus fumigatus - isolation & purification (253) 253
recipients (253) 253
child, preschool (252) 252
internal medicine (252) 252
aged, 80 and over (251) 251
tomography, x-ray computed (250) 250
candida-albicans (247) 247
dermatology (242) 242
medicine, general & internal (241) 241
fluconazole (240) 240
invasive pulmonary aspergillosis - microbiology (239) 239
surgery (239) 239
antifungal agents - adverse effects (238) 238
pediatrics (231) 231
patients (227) 227
pneumonia (224) 224
cell transplant recipients (223) 223
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4985) 4985
French (125) 125
Spanish (82) 82
German (61) 61
Japanese (42) 42
Chinese (30) 30
Korean (19) 19
Turkish (16) 16
Russian (6) 6
Portuguese (4) 4
Polish (3) 3
Czech (2) 2
Italian (2) 2
Slovak (2) 2
Arabic (1) 1
Dutch (1) 1
Lithuanian (1) 1
Serbian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Respiratory Journal, ISSN 0903-1936, 01/2016, Volume 47, Issue 1, pp. 45 - 68
Chronic pulmonary aspergillosis (CPA) is an uncommon and problematic pulmonary disease, complicating many other respiratory disorders, thought to affect... 
LUNG-CANCER | BRONCHIAL ARTERY EMBOLIZATION | RESPIRATORY SYSTEM | LONG-TERM OUTCOMES | GALACTOMANNAN ANTIGEN | ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS | GEORGES RESPIRATORY QUESTIONNAIRE | CASE SERIES | AMPHOTERICIN-B | SURGICAL-TREATMENT | SEVERE HEMOPTYSIS | Antifibrinolytic Agents - therapeutic use | Pulmonary Aspergillosis - complications | Humans | Aspergillosis, Allergic Bronchopulmonary - complications | Pulmonary Aspergillosis - therapy | Tomography, X-Ray Computed | Lung - diagnostic imaging | Pulmonary Aspergillosis - immunology | Antifungal Agents - therapeutic use | Aspergillosis, Allergic Bronchopulmonary - therapy | Thoracic Surgery, Video-Assisted | Bronchial Arteries | Immunocompetence | Embolization, Therapeutic - methods | Mycetoma - complications | Aspergillosis, Allergic Bronchopulmonary - diagnosis | Bronchoscopy | Invasive Pulmonary Aspergillosis - therapy | Invasive Pulmonary Aspergillosis - immunology | Mycetoma - immunology | Pulmonary Aspergillosis - diagnosis | Tranexamic Acid - therapeutic use | Invasive Pulmonary Aspergillosis - diagnosis | Hemoptysis - therapy | Aspergillosis, Allergic Bronchopulmonary - immunology | Mycetoma - diagnosis | Disease Management | Mycetoma - therapy | Immunocompromised Host | Lung - surgery | Chronic Disease | Invasive Pulmonary Aspergillosis - complications | Hemoptysis - etiology | Index Medicus
Journal Article
Diagnostic and Interventional Imaging, ISSN 2211-5684, 2015, Volume 96, Issue 5, pp. 435 - 442
Journal Article
Respiratory Medicine, ISSN 0954-6111, 08/2018, Volume 141, pp. 121 - 131
Notable progress has been made in the past years in the classification, diagnosis and treatment of pulmonary aspergillosis. New criteria were proposed by the... 
Aspergillus | Chronic pulmonary aspergillosis | Invasive aspergillosis | Pulmonary aspergillosis | Allergic bronchopulmonary aspergillosis | BRONCHOALVEOLAR LAVAGE FLUID | SEVERE ASTHMA | CARDIAC & CARDIOVASCULAR SYSTEMS | COLONY-STIMULATING FACTOR | CHRONIC GRANULOMATOUS-DISEASE | RANDOMIZED-TRIAL | CLINICAL CHARACTERISTICS | INVASIVE FUNGAL-INFECTIONS | RESPIRATORY SYSTEM | GALACTOMANNAN ANTIGEN | CYSTIC-FIBROSIS | Invasive Pulmonary Aspergillosis - drug therapy | Recurrence | Triazoles - administration & dosage | Pulmonary Aspergillosis - drug therapy | Prognosis | Pyridines - administration & dosage | Humans | Environmental Exposure - prevention & control | Pulmonary Aspergillosis - diagnosis | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Pulmonary Aspergillosis - microbiology | Invasive Pulmonary Aspergillosis - diagnosis | Antifungal Agents - therapeutic use | Environmental Exposure - adverse effects | Fungi | Nitriles - administration & dosage | Pulmonary Aspergillosis - epidemiology | Aspergillus - isolation & purification | Aspergillosis, Allergic Bronchopulmonary - diagnosis | Nitriles - therapeutic use | Pyridines - therapeutic use | Triazoles - therapeutic use | Sleep disorders | Medical colleges | Triazoles | Communicable diseases | Cystic fibrosis | Respiratory agents | Drug approval | Risk factors | Therapy | Regulatory agencies | Medical imaging | Microbiology | Mycology | Medical treatment | Medical services | Molds | Infections | Medical diagnosis | Patients | Asthma | Infectious diseases | Classification | Aspergillosis | Chronic obstructive pulmonary disease | Diagnosis | Clinical microbiology | Immune system
Journal Article
Journal Article
REVUE DES MALADIES RESPIRATOIRES, ISSN 0761-8425, 02/2018, Volume 35, Issue 2, pp. 171 - 187
Journal Article
European Respiratory Journal, ISSN 0903-1936, 10/2007, Volume 30, Issue 4, pp. 782 - 800
Aspergillus spp. cultured in specimens from the airways of chronic obstructive pulmonary disease (COPD) patients are frequently considered as a contaminant.... 
Chronic obstructive pulmonary disease | Infection in chronic obstructive pulmonary disease | Invasive pulmonary aspergillosis | Fungal infection | Aspergillosis | BRONCHOALVEOLAR LAVAGE FLUID | COLONY-STIMULATING FACTOR | LINKED-IMMUNOSORBENT-ASSAY | COMPUTED TOMOGRAPHIC SCAN | BONE-MARROW-TRANSPLANTATION | invasive pulmonary aspergillosis | CELL TRANSPLANT RECIPIENTS | REAL-TIME PCR | fungal infection | POLYMERASE-CHAIN-REACTION | INTENSIVE-CARE-UNIT | RESPIRATORY SYSTEM | NECROTIZING BRONCHIAL ASPERGILLOSIS | aspergillosis | infection in chronic obstructive pulmonary disease | chronic obstructive pulmonary disease | Antifungal Agents - pharmacology | Pulmonary Disease, Chronic Obstructive - mortality | Sputum - microbiology | Lung Diseases, Fungal - diagnosis | Prognosis | Aspergillosis, Allergic Bronchopulmonary - microbiology | Pulmonary Disease, Chronic Obstructive - microbiology | Humans | Middle Aged | Bronchoscopy - methods | Adrenal Cortex Hormones - pharmacology | Aspergillosis, Allergic Bronchopulmonary - complications | Male | Tomography, X-Ray Computed | Treatment Outcome | Pulmonary Disease, Chronic Obstructive - complications | Aspergillus - metabolism | Pulmonary Disease, Chronic Obstructive - epidemiology | Lung Diseases, Fungal - microbiology | Lung Diseases, Fungal - mortality | Aspergillosis, Allergic Bronchopulmonary - mortality | Female | Aged | Aspergillosis, Allergic Bronchopulmonary - epidemiology
Journal Article
Advances in experimental medicine and biology, ISSN 0065-2598, 2017, Volume 944, p. 27
Culturing strains from clinical samples is the main method to diagnose invasive pulmonary aspergillosis. Detecting the galactomannan antigen in serum samples... 
Antigens, Fungal - blood | Humans | Mannans - blood | Invasive Pulmonary Aspergillosis - blood | Poland | Retrospective Studies | Aspergillus fumigatus - pathogenicity | Invasive Pulmonary Aspergillosis - diagnosis | Bronchoalveolar Lavage Fluid - microbiology
Journal Article
Journal Article